Oragenics

Contributing Author

Recent Articles by Oragenics

5 hours	Oragenics Completes Approximately $16.5 Million Offering OGEN -7.10% GlobeNewswire
Jul-01	Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants OGEN GlobeNewswire
Jun-10	Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium OGEN GlobeNewswire
May-28	Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split OGEN GlobeNewswire
May-13	Oragenics, Inc. Announces Approval to Initiate Phase II Concussion Drug Trial in Australia OGEN GlobeNewswire
May-12	Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision OGEN GlobeNewswire